Leavell Investment Management Inc. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 19.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 17,840 shares of the healthcare conglomerate’s stock after selling 4,366 shares during the quarter. Leavell Investment Management Inc.’s holdings in UnitedHealth Group were worth $9,025,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently modified their holdings of the company. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. Friedenthal Financial acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $51,000. Highline Wealth Partners LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group in the third quarter worth $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Trading Up 0.1 %
NYSE UNH opened at $533.99 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a 50-day simple moving average of $527.67 and a 200 day simple moving average of $564.22. The company has a market capitalization of $491.42 billion, a PE ratio of 34.45, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
Wall Street Analyst Weigh In
A number of equities analysts have commented on UNH shares. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.
View Our Latest Report on UnitedHealth Group
Insiders Place Their Bets
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Learn Technical Analysis Skills to Master the Stock Market
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- P/E Ratio Calculation: How to Assess Stocks
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Using the MarketBeat Stock Split Calculator
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.